Ann MacDougall
Direktor/Vorstandsmitglied bei ALOPEXX, INC.
Profil
Ann MacDougall is an Independent Director at Alopexx, Inc., Director at Atmos Xr, and Director at Strongminds Zambia.
She was formerly the Chairman at Progenics Pharmaceuticals, Inc., Independent Director at Opiant Pharmaceuticals, Inc., General Counsel at PricewaterhouseCoopers LLP, Principal at US West, Inc., Chief Administrative Officer at Acumen Fund, Inc., President at Encore.
Org, and worked at Coopers & Lybrand LLP.
She received her undergraduate degree from Tufts University and her graduate degree from Brooklyn Law School.
Aktive Positionen von Ann MacDougall
| Unternehmen | Position | Beginn |
|---|---|---|
| ALOPEXX, INC. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ann MacDougall
| Unternehmen | Position | Ende |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 02.03.2023 |
| PROGENICS PHARMACEUTICALS, INC. | Vorsitzender | 19.06.2020 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01.01.2007 |
| US West, Inc. | Corporate Officer/Principal | - |
Ausbildung von Ann MacDougall
| Brooklyn Law School | Graduate Degree |
| Tufts University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Acumen Fund, Inc.
 Acumen Fund, Inc. Investment ManagersFinance Acumen Fund, Inc (Acumen Fund) is a venture capital firm founded in 2001 by Jacqueline Novogratz. The firm is headquartered in New York. | Finance |
| US West, Inc. | Communications |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
